Advertisement Cardium completes $5.3 million registered direct offering - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Cardium completes $5.3 million registered direct offering

Cardium Therapeutics has completed its $5.3 million registered direct offering with institutional and other accredited or qualified investors that was previously announced on January 31, 2008.

Empire Asset Management Company acted as the sole placement agent for the transaction.